Trial · NCT02783573
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Placebo-Controlled Treatment Period | STARTED | Placebo | 562 | |
| Placebo-Controlled Treatment Period | STARTED | Lanabecestat 20 Milligrams (mg) | 590 | |
| Placebo-Controlled Treatment Period | STARTED | Lanabecestat 50 mg | 570 | |
| Placebo-Controlled Treatment Period | Received at Least 1 Dose of Study Drug | Placebo | 558 | |
| Placebo-Controlled Treatment Period | Received at Least 1 Dose of Study Drug | Lanabecestat 20 Milligrams (mg) | 588 | |
| Placebo-Controlled Treatment Period | Received at Least 1 Dose of Study Drug | Lanabecestat 50 mg | 568 | |
| Placebo-Controlled Treatment Period | COMPLETED | Placebo | 26 | |
| Placebo-Controlled Treatment Period | COMPLETED | Lanabecestat 20 Milligrams (mg) | 28 | |
| Placebo-Controlled Treatment Period | COMPLETED | Lanabecestat 50 mg | 22 | |
| Placebo-Controlled Treatment Period | NOT COMPLETED | Placebo | 536 | |
| Placebo-Controlled Treatment Period | NOT COMPLETED | Lanabecestat 20 Milligrams (mg) | 562 | |
| Placebo-Controlled Treatment Period | NOT COMPLETED | Lanabecestat 50 mg | 548 | |
| Delayed-Start Period | STARTED | Placebo | 0 | |
| Delayed-Start Period | STARTED | Lanabecestat 20 Milligrams (mg) | 17 | |
| Delayed-Start Period | STARTED | Lanabecestat 50 mg | 12 | |
| Delayed-Start Period | Received at Least 1 Dose of Study Drug | Placebo | 0 | |
| Delayed-Start Period | Received at Least 1 Dose of Study Drug | Lanabecestat 20 Milligrams (mg) | 14 | |
| Delayed-Start Period | Received at Least 1 Dose of Study Drug | Lanabecestat 50 mg | 12 | |
| Delayed-Start Period | COMPLETED | Placebo | 0 | |
| Delayed-Start Period | COMPLETED | Lanabecestat 20 Milligrams (mg) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02783573/flow